ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28th at 8:30 ...
The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...
Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...